The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients
- Sponsor
- Gerhard Rogler
- Study ID
- NCT01012570
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Application of Adalimumab — DRUGAdalimumab will be applied according to manufacture's instruction and official guidelines.
Study Details
The investigators will study the effect of Adalimumab on the bone microstructure. * Trial with medicinal product
Key Dates
- First listed
- Nov 13, 2009
- Start date
- Aug 31, 2009
- Status verified
- Dec 2014
- Primary completion
- Aug 31, 2011
Study Design
- Enrollment
- 34 participants (actual)
Find similar trials
Related Studies
- Autologous Stem Cell Transplantation for Crohn's DiseasePHASE1/PHASE2 · Recruiting · Paul Szabolcs · Pittsburgh, Pennsylvania
- Fecal Microbiome TransplantPHASE1 · Enrolling By Invitation · Judith Kelsen · Philadelphia, Pennsylvania
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With UstekinumabPHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland